company background image
MAYBAKER logo

May & Baker Nigeria NGSE:MAYBAKER Stock Report

Last Price

₦7.75

Market Cap

₦13.4b

7D

1.3%

1Y

50.5%

Updated

05 Dec, 2024

Data

Company Financials

May & Baker Nigeria plc

NGSE:MAYBAKER Stock Report

Market Cap: ₦13.4b

MAYBAKER Stock Overview

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. More details

MAYBAKER fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends2/6

May & Baker Nigeria plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for May & Baker Nigeria
Historical stock prices
Current Share Price₦7.75
52 Week High₦8.50
52 Week Low₦4.75
Beta-0.022
11 Month Change1.97%
3 Month Change10.71%
1 Year Change50.49%
33 Year Change84.52%
5 Year Change262.15%
Change since IPO478.67%

Recent News & Updates

Recent updates

Shareholder Returns

MAYBAKERNG PharmaceuticalsNG Market
7D1.3%2.7%1.1%
1Y50.5%-5.0%51.6%

Return vs Industry: MAYBAKER exceeded the NG Pharmaceuticals industry which returned -5% over the past year.

Return vs Market: MAYBAKER underperformed the NG Market which returned 51.6% over the past year.

Price Volatility

Is MAYBAKER's price volatile compared to industry and market?
MAYBAKER volatility
MAYBAKER Average Weekly Movement4.7%
Pharmaceuticals Industry Average Movement6.6%
Market Average Movement6.2%
10% most volatile stocks in NG Market9.2%
10% least volatile stocks in NG Market3.2%

Stable Share Price: MAYBAKER has not had significant price volatility in the past 3 months compared to the NG market.

Volatility Over Time: MAYBAKER's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1944388Patrick Ajahmay-baker.com

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products.

May & Baker Nigeria plc Fundamentals Summary

How do May & Baker Nigeria's earnings and revenue compare to its market cap?
MAYBAKER fundamental statistics
Market cap₦13.37b
Earnings (TTM)₦2.26b
Revenue (TTM)₦27.22b

5.9x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MAYBAKER income statement (TTM)
Revenue₦27.22b
Cost of Revenue₦18.74b
Gross Profit₦8.47b
Other Expenses₦6.21b
Earnings₦2.26b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.31
Gross Margin31.14%
Net Profit Margin8.30%
Debt/Equity Ratio49.8%

How did MAYBAKER perform over the long term?

See historical performance and comparison

Dividends

3.9%

Current Dividend Yield

67%

Payout Ratio